Pierre Gravier insider trades

Open-market stock purchases and sales by Pierre Gravier, CHIEF FINANCIAL OFFICER at PTC Therapeutics, Inc, from SEC Form 4 filings since Jul 13, 2023.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +153%.

Recent trades

DateStockTradeValue
Jul 14, 2026PTCT PTC Therapeutics, IncSold$281K
Feb 18, 2026PTCT PTC Therapeutics, IncSold$208K
Jan 6, 2026PTCT PTC Therapeutics, IncSold$165K
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—

Companies traded

  • PTCT PTC Therapeutics, Inc: 1 buy, 7 sales, last Jul 14, 2026
  • SAVA Cassava Sciences Inc: other filings, last May 23, 2025

Get free alerts when Pierre Gravier files a new trade →